- Home
- CRIS vs PYN Comparison
CRIS vs PYN Comparison
Compare CRIS & PYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRIS
- PYN
- Stock Information
- Founded
- CRIS 2000
- PYN 2002
- Country
- CRIS United States
- PYN United States
- Employees
- CRIS N/A
- PYN N/A
- Industry
- CRIS Biotechnology: Biological Products (No Diagnostic Substances)
- PYN Investment Managers
- Sector
- CRIS Health Care
- PYN Finance
- Exchange
- CRIS Nasdaq
- PYN Nasdaq
- Market Cap
- CRIS 21.3M
- PYN 30.4M
- IPO Year
- CRIS 2000
- PYN N/A
- Fundamental
- Price
- CRIS $2.32
- PYN $5.27
- Analyst Decision
- CRIS Strong Buy
- PYN
- Analyst Count
- CRIS 2
- PYN 0
- Target Price
- CRIS $16.50
- PYN N/A
- AVG Volume (30 Days)
- CRIS 71.8K
- PYN 19.9K
- Earning Date
- CRIS 07-31-2025
- PYN 01-01-0001
- Dividend Yield
- CRIS N/A
- PYN 5.07%
- EPS Growth
- CRIS N/A
- PYN N/A
- EPS
- CRIS N/A
- PYN N/A
- Revenue
- CRIS $11,202,000.00
- PYN N/A
- Revenue This Year
- CRIS N/A
- PYN N/A
- Revenue Next Year
- CRIS $10.67
- PYN N/A
- P/E Ratio
- CRIS N/A
- PYN N/A
- Revenue Growth
- CRIS 14.17
- PYN N/A
- 52 Week Low
- CRIS $1.02
- PYN $4.84
- 52 Week High
- CRIS $8.29
- PYN $6.60
- Technical
- Relative Strength Index (RSI)
- CRIS 52.52
- PYN 36.70
- Support Level
- CRIS $2.11
- PYN $5.22
- Resistance Level
- CRIS $2.26
- PYN $5.28
- Average True Range (ATR)
- CRIS 0.21
- PYN 0.05
- MACD
- CRIS -0.04
- PYN -0.00
- Stochastic Oscillator
- CRIS 21.36
- PYN 18.18
About CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.
About PYN PIMCO New York Municipal Income Fund III of Beneficial Interest
PIMCO New York Municipal Income Fund III is a closed-end management investment company. Its investment objective is to seek to provide current income exempt from federal, New York State, and New York City income tax. To pursue the objectives, the fund invests a majority of its net assets in municipal bonds that pay interest that is exempt from federal, New York State, and New York City income tax.